Alcoholic hepatitis is a serious liver condition that requires immediate attention and a carefully planned approach to treatment. The main goal is to stop further liver damage, reduce inflammation, and support the body’s ability to heal. Treatment decisions depend on how severe the disease is, whether the person has other health problems, and most importantly, whether they can stop drinking alcohol completely.

Understanding Treatment Goals in Alcoholic Hepatitis

When someone is diagnosed with alcoholic hepatitis, the primary focus shifts toward preventing permanent damage to the liver and helping this vital organ begin to heal so it can function normally again. Alcoholic hepatitis, sometimes now called alcohol-associated hepatitis to emphasize its medical nature, represents a critical stage of liver inflammation caused by excessive alcohol consumption over time.^[1]

The treatment approach varies significantly depending on the severity of the illness. In mild cases, the condition may improve on its own with proper care and complete alcohol abstinence. However, severe alcoholic hepatitis carries a much more serious outlook, with high rates of complications including infections, organ failure, and death within just 30 days if not treated appropriately.^[6]

Medical societies and liver specialists have developed guidelines to help doctors determine which treatments are most appropriate for each patient. These guidelines consider various factors such as blood test results, the presence of complications like confusion or fluid buildup in the abdomen, and whether the person has underlying cirrhosis (permanent scarring of the liver). The treatment plan also must address alcohol dependence, which affects an estimated 70% of people with this condition.^[4]

Beyond standard treatments that doctors use routinely in hospitals, researchers are actively testing new therapies in clinical trials. These experimental approaches aim to improve outcomes for patients who don’t respond to current treatments or who cannot receive them due to complications such as active infections.^[10]

Standard Treatment Approaches

Stopping Alcohol Consumption

The single most important treatment for alcoholic hepatitis is complete and permanent cessation of alcohol use. This step is absolutely essential regardless of how mild or severe the condition is. For people with mild alcoholic hepatitis, stopping drinking may be the only treatment needed, as the liver has a remarkable ability to regenerate if given the chance.^[4]

In cases of severe alcoholic hepatitis, continued alcohol consumption dramatically increases the risk of liver failure and death. Studies consistently show that abstinence from alcohol is the only intervention proven to improve liver function over the long term, prevent progression to cirrhosis, and reduce mortality. Even if someone already has cirrhosis, stopping alcohol can significantly increase life expectancy.^[6]

However, stopping alcohol is extremely difficult for most patients, especially those who have developed alcohol use disorder (a medical condition characterized by inability to stop or control alcohol use despite harmful consequences). Many people require structured support through alcohol treatment programs. During the initial days and weeks after stopping, patients may experience withdrawal symptoms including tremors, anxiety, sweating, nausea, disturbed sleep, and in severe cases, confusion or seizures.^[4]

To help manage withdrawal safely, doctors may prescribe medications called benzodiazepines, which calm the nervous system and reduce the risk of dangerous complications during withdrawal. Psychological therapy, particularly cognitive behavioral therapy (a type of counseling that helps change thinking patterns and behaviors), is also offered to help patients understand their relationship with alcohol and develop strategies to maintain abstinence.^[9]

For long-term abstinence, certain medications can help reduce cravings and prevent relapse. Naltrexone is particularly effective at decreasing the urge to drink and is available as a daily pill or as a monthly injection called Vivitrol. Other medications used include acamprosate and disulfiram, each working through different mechanisms to support sobriety.^[6][21]

Nutritional Support

People with alcoholic hepatitis are almost always malnourished, even if they don’t appear underweight. Alcohol provides calories but no nutrients, and heavy drinking damages the digestive system’s ability to absorb vitamins and minerals. The liver itself, when damaged, cannot store glycogen (a form of sugar the body uses for quick energy), which means the body starts breaking down muscle tissue for energy instead.^[6]

Proper nutrition is a cornerstone of treatment. Medical guidelines recommend that patients receive a daily energy intake of 35 to 40 calories per kilogram of body weight, along with 1.2 to 1.5 grams of protein per kilogram of body weight. This translates to roughly 2,400 to 2,800 calories and 84 to 105 grams of protein daily for a 70-kilogram (154-pound) person. Eating small, frequent meals throughout the day, rather than one or two large meals, helps maintain energy levels and prevents muscle breakdown.^[6]

Vitamin and mineral supplementation is essential. Nearly all patients need supplemental B vitamins, particularly thiamine (vitamin B1) and folate (vitamin B9), as deficiencies are common and can cause serious neurological problems. Vitamin K may be given by injection to patients whose blood doesn’t clot properly, as this vitamin is necessary for producing clotting factors in the liver.^[16]

In severe cases where patients cannot eat enough by mouth due to nausea, loss of appetite, or altered mental status, nutrition may need to be provided through a feeding tube inserted through the nose into the stomach. This ensures that critically ill patients receive adequate calories and protein to support healing and prevent further muscle wasting.^[6]

Corticosteroids for Severe Cases

For patients with severe alcoholic hepatitis, corticosteroids (powerful anti-inflammatory medications) are the current standard of care. The most commonly used corticosteroid is prednisolone, typically given at a dose of 40 milligrams daily for 28 days. These medications work by suppressing the immune system’s inflammatory response, which in severe alcoholic hepatitis has become harmful rather than helpful.^[6]

Doctors determine severity using scoring systems based on blood test results. The Maddrey Discriminant Function score and the Model for End-Stage Liver Disease (MELD) score are the most widely used. A Maddrey score of 32 or higher, or a MELD score above 20, indicates severe disease that may benefit from corticosteroid therapy. These scores take into account factors such as bilirubin levels (a waste product that causes yellowing of the skin when elevated), clotting ability, and kidney function.^[6]

However, corticosteroids are not appropriate for everyone. They should not be given to patients with active infections, uncontrolled gastrointestinal bleeding, or kidney failure. Before starting corticosteroids, doctors order chest X-rays and cultures of blood, urine, and abdominal fluid to rule out infections. Throughout treatment, patients require close monitoring because corticosteroids can mask signs of infection and may worsen blood sugar control.^[6]

After 7 days of corticosteroid treatment, doctors assess whether the therapy is working using the Lille score, which combines changes in bilirubin levels with other clinical information. A Lille score below 0.45 suggests the patient is responding to treatment and should continue the full 28-day course. A score above 0.45 indicates non-response, and continuing corticosteroids in these patients provides no benefit and exposes them to unnecessary side effects. The treatment is then stopped.^[6]

About 60% of patients with severe alcoholic hepatitis respond to corticosteroid therapy with improvement in liver function and survival. However, even among responders, the benefits are primarily short-term. Long-term survival depends entirely on whether the person remains abstinent from alcohol after hospital discharge.^[10]

Supportive Care and Complication Management

Whether or not corticosteroids are used, all patients with severe alcoholic hepatitis require intensive supportive care, often in an intensive care unit. This involves careful monitoring and treatment of the many complications that can arise, including kidney failure, infections, bleeding, and confusion due to toxins building up in the bloodstream.^[6]

Infections are particularly common and dangerous, occurring in up to 50% of patients with severe alcoholic hepatitis. The most frequent infections include pneumonia, urinary tract infections, and spontaneous bacterial peritonitis (infection of fluid in the abdomen). Any fever or worsening of symptoms should prompt immediate investigation and treatment with antibiotics.^[12]

Managing fluid balance is crucial. Many patients develop ascites (fluid accumulation in the abdomen), which may require treatment with diuretic medications to increase urination and remove excess fluid. Salt restriction helps prevent fluid retention. In some cases, fluid must be drained from the abdomen using a needle, a procedure called paracentesis, to relieve pressure and check for infection.^[4]

Hepatic encephalopathy (confusion and altered mental state caused by toxins the damaged liver cannot remove) requires treatment with a medication called lactulose, which helps remove ammonia from the body through the bowels. Severe cases may also require antibiotics such as rifaximin to reduce bacteria in the intestines that produce ammonia.^[12]

Treatment in Clinical Trials

For patients who cannot receive corticosteroids, don’t respond to them, or have very severe disease, researchers are testing several promising new approaches in clinical trials around the world, including in the United States, Europe, and other regions.

N-Acetylcysteine

N-acetylcysteine (NAC) is an antioxidant medication that helps protect liver cells from damage caused by toxic substances. In alcoholic hepatitis, alcohol breaks down into harmful compounds that create oxidative stress (cellular damage from unstable molecules called free radicals). NAC replenishes the liver’s natural antioxidant defenses and may improve blood flow to the liver.^[10]

Clinical trials have tested NAC in combination with corticosteroids. One significant trial found that adding NAC to prednisolone reduced the risk of hepatorenal syndrome (a type of kidney failure that occurs with severe liver disease) and improved survival at one month compared to prednisolone alone. However, the survival benefit did not extend beyond three months. NAC is given intravenously in the hospital, typically for five days.^[10]

While not universally adopted, some hospitals now use NAC routinely in combination with corticosteroids for severe alcoholic hepatitis, particularly in patients at high risk for kidney complications. The medication is generally safe with few side effects.^[15]

Targeting Gut Bacteria and Inflammation

Researchers have discovered that alcoholic hepatitis involves not just direct liver damage from alcohol but also harmful changes in gut bacteria and increased intestinal permeability. Heavy alcohol consumption damages the intestinal lining, allowing bacteria and bacterial products such as lipopolysaccharide (LPS) (a component of certain bacterial cell walls) to leak into the bloodstream. When LPS reaches the liver, it triggers intense inflammation.^[15]

Several clinical trials are testing treatments aimed at modifying gut bacteria composition or reducing their harmful effects. Probiotics (beneficial bacteria) and antibiotics that target specific intestinal bacteria are being studied to see if they can reduce inflammation and improve liver function. Early Phase II trials are evaluating whether these approaches can benefit patients who are ineligible for corticosteroids or don’t respond to them.^[15]

Granulocyte Colony-Stimulating Factor

Granulocyte colony-stimulating factor (G-CSF) is a naturally occurring protein that stimulates bone marrow to produce more white blood cells and may help damaged livers regenerate. The idea behind using G-CSF in alcoholic hepatitis is that it might mobilize stem cells that could help repair liver tissue and reduce inflammation.^[15]

Small clinical trials, particularly from India and Europe, have shown promising preliminary results. In these Phase II studies, patients receiving G-CSF injections showed improvements in liver function tests, reduced infection rates, and better survival compared to those receiving standard care alone. The medication is typically given as daily or every-other-day injections under the skin for several weeks.^[15]

However, larger Phase III trials are needed to confirm these findings before G-CSF can be recommended as standard treatment. These trials are currently ongoing in multiple countries to definitively determine whether G-CSF improves survival in severe alcoholic hepatitis.^[15]

Immune Modulation Therapies

The inflammatory response in severe alcoholic hepatitis is complex, involving multiple immune system pathways. Researchers are testing medications that target specific parts of this immune response, such as interleukin inhibitors (drugs that block specific inflammatory signaling molecules) and medications that modify how immune cells behave.^[15]

These approaches are still in early Phase I and Phase II trials to establish safety and proper dosing. The goal is to find ways to calm the harmful inflammation without completely suppressing the immune system, which would increase infection risk. Results from these trials are eagerly awaited by the medical community.^[15]

Liver Transplantation

For patients with severe alcoholic hepatitis who don’t respond to medical treatment and face imminent liver failure, liver transplantation may offer the only chance for survival. Traditionally, transplant centers required patients to be abstinent from alcohol for at least six months before being considered for transplant, partly to ensure commitment to sobriety and partly to see if the liver might recover with abstinence.^[10]

Recent clinical experience, particularly from several centers in Europe and the United States, has shown that carefully selected patients with severe alcoholic hepatitis can undergo early liver transplantation with good outcomes. Survival rates at one year after transplant are similar to those for other liver diseases. However, this approach remains controversial due to ethical concerns about organ allocation, the limited supply of donor organs, and worries about alcohol relapse after transplant.^[10]

Candidates for early transplant in alcoholic hepatitis are selected very carefully. Most programs require patients to have no previous history of alcohol treatment failure, strong family and social support, and agreement to participate in intensive addiction treatment programs after transplant. All transplant centers require lifelong abstinence from alcohol following transplantation.^[4]

Most common treatment methods

• Alcohol cessation and addiction treatment
  • Complete and permanent abstinence from alcohol is essential for recovery and long-term survival
  • Medically supervised withdrawal using benzodiazepines to manage symptoms safely
  • Cognitive behavioral therapy to address underlying alcohol use disorder
  • Medications to maintain abstinence including naltrexone, acamprosate, and disulfiram
  • Structured alcohol treatment programs and self-help groups for ongoing support
• Nutritional support and supplementation
  • High-calorie diet providing 35 to 40 kcal per kilogram of body weight daily
  • High-protein intake of 1.2 to 1.5 grams per kilogram of body weight daily
  • Small, frequent meals to prevent muscle breakdown and maintain energy
  • Vitamin supplementation including thiamine, folate, and other B vitamins
  • Vitamin K administration for patients with clotting abnormalities
  • Enteral nutrition through feeding tube when oral intake is insufficient
• Corticosteroid therapy
  • Prednisolone 40 mg daily for 28 days in severe cases without infection
  • Used when Maddrey Discriminant Function score is 32 or higher
  • Response evaluated at day 7 using Lille score to guide continuation
  • Approximately 60% of patients show improvement with this treatment
• Management of complications
  • Diuretics and salt restriction for ascites (fluid in abdomen)
  • Lactulose and rifaximin for hepatic encephalopathy (confusion)
  • Antibiotics for infections including spontaneous bacterial peritonitis
  • Monitoring and treatment of kidney function and electrolyte imbalances
  • Blood products for severe clotting abnormalities or bleeding
• Experimental therapies in clinical trials
  • N-acetylcysteine in combination with corticosteroids to reduce oxidative stress
  • Granulocyte colony-stimulating factor to promote liver regeneration
  • Probiotics and antibiotics to modify gut bacteria composition
  • Immune modulators targeting specific inflammatory pathways
  • Early liver transplantation for carefully selected patients with severe disease